Higher incidences of both childhood leukemia and allergic diseases are found in western industrialized countries compared with developing countries, and exposure to infectious agents has been linked to the pathogenesis of both diseases. Three independent hypotheses suggest a link between infections and childhood leukemia. Kinlen's 1 population mixing theory proposes that the incidence of childhood leukemia increases both among the immigrants and the original residents of a defined geographical region due to exposure to previously unencountered leukemogenic infections. Greave's 2 delayed infections hypothesis proposes that childhood acute lymphoblastic leukemia (ALL) is caused by two independent mutations; the first mutation occurs in utero, and if the child has limited exposure to early childhood infections, such infections willFwhen they occur later during childhoodFlead to an excessive proliferative stress on the preleukemic cells, which cause the necessary additional leukemogenic chromosomal aberrations. Finally, the adrenal hypothesis of Schmiegelow et al. 3 claims that the risk of childhood ALL is reduced, when early childhood infections increase plasma cortisol levels, as this may eliminate both leukemic and preleukemic cells for the ALL subsets that dominate in the first 5-7 years of life, and may further suppress the Th1-dominated (proinflammatory) response to infections, and thus lower the proliferative stress on preexisting preleukemic cells.
According to the hygiene hypothesis, lack of exposure to infections during early childhood is responsible for the increasing incidence of allergy in industrialized countries. 4 Thus, the decline in exposure to infections in early childhood might have a role both in the etiology of allergy as well as in childhood leukemia. To explore the association between allergy and childhood leukemia, we conducted a systematic literature review and a meta-analysis of the relationship between different types of allergies and childhood leukemia.
We identified all epidemiological studies published before November 2008 that investigated the association between childhood leukemia and allergic diseases through electronic searches in PubMed and EMBASE (without language restrictions). The index terms used in PubMed were [MeSH] ('Hypersensitivity' or 'Allergy and immunology') and 'Leukemia, Lymphoid' [MeSH] combined with 'All Child: 0-18 not Case Report'. Furthermore, we conducted a free-text search to identify publications that were not indexed. In EMBASE, the search terms were (exp acute lymphoblastic leukemia/ or exp acute lymphocytic leukemia/) and (exp HYPERSENSITIVITY/or exp hypersensitivity concepts/) limited to child ounspecified age4 not Case Report. In addition, we conducted a manual search of references in the already identified publications and review papers to identify studies missed in the database searches. Finally, we performed a manual search on the author name of persons known to us to be active in the field of childhood cancer epidemiology.
To be eligible, a study had to be an original report that presented data on the relationship between allergy and childhood leukemia. A study was included if it presented an adjusted or unadjusted relative risk estimate, including confidence intervals or information to allow their calculation. When publications reported in full or in part on the same study population, we used the publication with the largest study population. If the publication was an abstract, an editorial or a review, we conducted a manual search to find the original publications on which they were based.
A group of three authors (LSS, TV and SD) independently extracted data using standardized forms. All statistical analyses were conducted using the statistical package STATA Version 9 (Stata Corp Lp College Station, TX, USA) (Meta command). To investigate the presence of publication bias, we used Egger's regression asymmetry statistics and the Begg and Mazumdar adjusted rank correlation test, and graphically evaluated the asymmetry using a funnel plot. To evaluate whether the included studies were heterogeneous, we used Cochran's Q-test. In addition, we estimated the corresponding quantity I 2 , which quantifies the inconsistency across studies that are due to heterogeneity rather than chance, wherein larger values indicate increasing heterogeneity. We only used the adjusted estimates in our analyses apart from two studies for which it was not available (overall childhood leukemia).
The characteristics and reference of the individual studies are listed in Table 1 . Overall, 11 studies were included in the metaanalysis, all published between 1964 and 2007. They were all case-control studies. In total, the eleven studies included 5659 cases of childhood leukemia (4522 specified as ALL and 327 specified as acute myeloblastic leukemia (AML)) and 9569 controls. All studies used medically confirmed acute childhood leukemia, ALL or AML, as outcome and self-reported or physician-diagnosed allergic conditions as exposure. The definition of exposure was very heterogeneous and reached from any allergy (not further specified) to clinical allergy by strict diagnostic criteria. Furthermore, the exposure subtypes investigated in the individual studies ranged within the total spectrum of hypersensitivities, including eczema, hay fever, asthma, neurodermatitis, hives, food-drug allergy and atopic disease. Table 1 lists the four studies that fulfilled the search criteria, but were excluded from the analyses.
As two studies showed substantial dissimilarity between the adjusted estimates given in the papers and our calculated crude odds ratio (OR) of each study based on the number of exposed and non-exposed cases and controls, we chose to use the adjusted OR obtained from all studies for the calculation of the summary estimates.
Egger's test and the Begg and Mazumdar test indicated no presence of publication bias (P ¼ 0.402 and P ¼ 0.276, respectively). The Cochrane Q-test suggested a statistically significant heterogeneity with a P-value of 0.001 (Q ¼ 28.9 on 10 degrees of freedom) for studies included in the overall allergy analysis. The I 2 quantity was 65%, confirming that the effect of heterogeneity on meta-analysis was substantial. Therefore, all summary estimates presented in this study are based on the random effect model. In a sensitivity analysis, we evaluated the overall heterogeneity and the robustness of the summary OR by leaving out one study at a time. This showed, that the Hughes study was the one primarily contributing to the observed heterogeneity; however, this study, similar to the summary estimate, also showed an inverse association, only somewhat weaker (Hughes OR: 0.87, summary OR: 0.71). All summary estimates obtained from the sensitivity analysis were within the confidence interval of the summary OR of all the 11 studies.
The study-specific ORs for childhood leukemia ranged from 0.26 to 1.24 for the overall allergy value. Nine of eleven studies (Figure 1a , eight studies). Three studies investigated the relationship between AML and allergies; all were based on sparse data and showed a statistically non-significant inverse association. In general, the definitions of exposure and assessment in the individual studies were very diverse. Figure 1b, 
2 ¼ 29%Fminor influence). The summary estimates were statistically significantly decreased for the eczema and hay fever subgroup analyses, but not for asthma.
Stratification of the analyses by major cytogenetic subgroups (e.g., BCR-ABL1 or TEL-AML1) could not be done, as all studies lacked such data. One study compared the relationship between allergies and the age at diagnosis of leukemia, and did not indicate an interaction between age and the overall allergy/ALL OR (data not shown).
Although the inverse association between the risk of ALL and allergy seems to be counterintuitive, as both diseases are related to a low exposure to infectious agents in early life and to a low number of siblings, the present meta-analysis suggests this association to be real. However, both allergy and childhood leukemia are very heterogeneous groups of diseases. Thus, it is possible that the inverse association may only be linked to specific subgroups of either disease. Leukemia subsets correlate strongly with age at diagnosis, and the slightly stronger inverse association between allergy and leukemia in the younger age group could reflect the very high proportion of the TEL-AML1-translocation positive and high-hyperdiploid leukemia in the 2-7 years age group. However, current data do not allow reliable conclusions to be drawn with regard to ALL subtype associations. Furthermore, several studies investigating the association between non-Hodgkin's lymphoma and atopic disease also show an inverse correlation. 5 This supports our data, as ALL and non-Hodgkin's lymphoma are both biologically and clinically closely related.
Allergy is due to hypersensitivity reaction caused by antibody or cellular-mediated immune mechanism, of which the former can be either IgE (immunoglobulin E) or non-IgE mediated. IgE-mediated hypersensitivity can be both atopic and non-atopic. The inverse association between allergy and cancer has been linked to the atopic subtype, which reflects a predominant Th2-phenotype and primed IgE immune response. The classical atopic diseases are asthma, eczema and hay fever; in this study all three were associated with a decreased risk of ALL. Only the asthma subgroup estimate was not statistically significant. A wide range of conditions, especially bronchitis in children can be mistaken for asthma, and only approximately 60-80% of children with asthma have the atopic subtype, which could have weakened the observed association between asthma and ALL. It is conceivable that the analysis of allergic subtypes is more accurate than the overall allergy estimate in describing the association, given the diverse definitions of allergies in the respective studies. This is supported by our finding, that less heterogeneity was found when calculating summary OR estimates for specific allergies compared with overall allergy.
Recall bias is a major methodological concern. Questionnaires and personal interviews rely on the parent's ability to Letters to the Editor recall past events. Parents of cases may find it easier to remember whether their child was diagnosed with allergy before the leukemia diagnosis. Control parents may have included allergies diagnosed after the index date, as they lack the milestone memory of a specific event. This bias could operate toward a spurious association. Databases and medical records, on the other hand, provide better information on the date of diagnosis. Hughes et al. showed that allergies registered in hospital or general practitioner records may differ from selfreported allergies, which indicates possible heterogeneity between the two types of data ascertainment. A possible bias related to data ascertainment from databases/medical records is that cases are known to have several hospitalizations, whereas their matched controls might have fewer; therefore, controls have a lower chance of being questioned about their allergic conditions. This would dilute the protective effect of allergy. The case-control response rates were high (460%), indicating that selection bias is probably not likely to explain the inverse association. However, some studies reported a generally higher socioeconomic status among controls than cases, and allergies are more common in more affluent families. Many of the questionnaire-based studies excluded cases that were very sick, and response rates were often lower among families of deceased cases. This means that a specific group of cases is often not included. However, even if allergy is related to the risk of developing ALL it is unlikely that it is related to the course of the clinical disease.
Publication bias is important to consider in a meta-analysis conducted on observational studies, but we found no evidence for publication bias. Childhood leukemia is a rare disease; therefore, all articles included in this meta-analysis are case-control studies, with classical limitations as described above by the retrospective ascertainment of exposure and the difficulty of recruiting an unbiased control group. All the individual methodological shortcomings of the included studies are also effective in the metaanalysis. In addition, the definitions of exposure and assessment in the individual studies were very diverse.
We identified heterogeneity across studies when combining them. The Wen study had the largest effect on the summary estimate, but it was not a major contributor to heterogeneity. The Hughes study contributed primarily to the heterogeneity; however, the study still observed an inverse association, only somewhat weaker than the other studies. Consequently, the removal of it only made the protective association stronger, thus supporting our thesis. Although the Spector study was the only study that found allergy to be a risk factor for childhood leukemia, its relatively little weight in the summary estimate and little contribution to heterogeneity showed that the study was well compatible with the remaining studies finding a protective effect. In the Spector study, the atopy/hives subgroup was associated with a significant increased risk. However, the association could be deceptive as the two diseases do not comprise the same immunological mechanisms. Atopy is associated with a type I allergic IgE response, and hives with a type I, II and III responses. In the study by Schü z, hives was associated with an increased risk of lymphatic-hematopoietic malignancies, and the fact that a positive association in the hives/atopy group is caused only by hives cannot be excluded. The Spector study includes only cases and controls that are 6 years or younger. As the incidence of allergic diseases correlates with age, one should expect the distribution of the allergy subgroups to be different from the other studies. However, the specific prevalence for the allergy subtypes corresponds well with the other studies, which might indicate influence by registration bias. Overall, it is unlikely that the strong statistically significant inverse association presented in our analysis is solely based on methodological bias or chance.
With regard to the biological plausibility of the observed empirical association, it has been proposed that individuals with allergic diseases may have an improved capability for immune surveillance. Thus, atopic disease is associated with a Th2-phenotype predominant immune system, and this can activate the B-cell mediated humoral immune response with IgE and Letters to the Editor eosinophil production. These immune mediators have been associated with a possible tumor cytotoxic effect. 6, 7 A natural killer cell-mediated anti-cancer effect has also been demonstrated, and patients with atopic asthma have shown increased natural killer cell activity against specific cancer cell lines. 8 However, a possible inverse association between mediators of the humoral immune response and ALL remains to be explored. Furthermore, according to the adrenal hypothesis by Schmiegelow, an increase in plasma cortisol levels in early childhood may destroy leukemic and preleukemic cells. 3 Two recent studies have shown that children with an atopic predisposition (parental atopy) have an increased cortisol response to stressful stimuli compared with non-predisposed children. 9, 10 This increased responsiveness of the hypothalamus-pituitary-adrenal axis in children with atopic dispositions could hypothetically lead to an elimination of ALL cells, because of their high glucocorticorticosteroid sensitivity and explain the protective role of allergy. Interestingly, two studies found parental allergy to be a protective factor for ALL (Schü z et al. and Rosenbaum et al.). Furthermore, the study by Schü z et al. found that parental atopic disease, even if the child was non-atopic, had an inverse association with ALL, thus supporting our thesis. In addition, the predominant Th-2 immune system in atopic individuals may be less capable of producing a Th1-mediated proliferative response to infections, which according to Greaves 'delayed infections hypothesis' is responsible for the second hit in the two-hit pathogenesis of ALL. However, further investigations are needed to show the role of the hypothalamus-pituitary-adrenal axis in the pathogenesis of both childhood leukemia and allergy.
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